Several studies, including those analyzing the ECLIPSE COPD cohort [16], [17], [18], [19], [20], have identified decreased circulating levels of the Clara cell protein CC-16 in patients with COPD, suggesting that this protein may be a marker of potential interest in predicting bronchial epithelial cell dysfunction. Here, SCGB1A1 is linked to chronic obstructive pulmonary disease.